Home › Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug
 

Keywords :   


Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug

2014-11-25 08:34:39| Biotech - Topix.net

Five Prime Therapeutics Inc. snagged a deal with Bristol-Myers Squibb Co. around one of the leading drugs in the emerging class of cancer-fighting drugs known as immune checkpoint inhibitors.

Tags: deal drug prime cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
26.06SWANA Publishes Report on the Performance of Seattles Zero Waste System
26.06Baltimore Sues Major Brands for Alleged Role in Plastic Pollution Crisis
26.06Petco Aims Sight at Large-Scale Recycling Program to Divert LDPE Plastic from Landfills
More »